Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

Overview of attention for article published in npj Genomic Medicine, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter: 13 X users

q&a: 1 Q&A thread

Readers on

mendeley: 65 Mendeley

So far, Altmetric has seen 16 X posts from 13 X users, with an upper bound of 72,659 followers.

@VDieriks I was interviewed last week and they had some awesome questions about ethics, authorship, logistics but I let them into a secret that the experiments weren’t done in the order presented in the paper -> 🤯 https://t.co/0W4j5vRstW

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer published as: https://t.co/1kxLYsXmcG #npj_Genomic_Medicine #biorxiv

Cancer: Frequent chromosome loss in rare pancreatic tumors #genomics https://t.co/Z8hRhZxNfH https://t.co/58rtqVDbct

#MTB cancerassassin1 shilpaonc Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer. https://t.co/yIXkO4qnw8

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.